{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:12:31Z","timestamp":1791825151633,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.autrev.2023.103391","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T05:19:29Z","timestamp":1689571169000},"page":"103391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Rheumatoid vasculitis in 2023: Changes and challenges since the biologics era"],"prefix":"10.1016","volume":"22","author":[{"given":"Philippe","family":"Mertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Wollenschlaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Dima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.autrev.2023.103391_bb0005","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality","volume":"38","author":"Turesson","year":"1999","journal-title":"Rheumatol Oxf Engl."},{"issue":"5","key":"10.1016\/j.autrev.2023.103391_bb0010","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/rheumatology\/ket475","article-title":"Vasculitis associated with rheumatoid arthritis: a case-control study","volume":"53","author":"Makol","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"10.1016\/j.autrev.2023.103391_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/rheumatology\/ket326","article-title":"Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy","volume":"53","author":"Ntatsaki","year":"2014","journal-title":"Rheumatol Oxf Engl."},{"issue":"9","key":"10.1016\/j.autrev.2023.103391_bb0020","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.22057","article-title":"Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis","volume":"54","author":"Turesson","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2023.103391_bb0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3899\/jrheum.161103","article-title":"Severe Extraarticular manifestations in a community-based cohort of patients with rheumatoid arthritis: risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors","volume":"44","author":"Theander","year":"2017","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103391_bb0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis","volume":"76","author":"Scott","year":"1984","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.autrev.2023.103391_bb0035","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1002\/art.20590","article-title":"No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study","volume":"50","author":"Turesson","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2023.103391_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.medcli.2020.01.024","article-title":"Rheumatoid vasculitis: study of 41 cases","volume":"155","author":"Oliv\u00e9","year":"2020","journal-title":"Med Clin (Barc)"},{"issue":"7","key":"10.1016\/j.autrev.2023.103391_bb0045","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/keh210","article-title":"Rheumatoid vasculitis: becoming extinct?","volume":"43","author":"Watts","year":"2004","journal-title":"Rheumatol Oxf Engl."},{"issue":"4","key":"10.1016\/j.autrev.2023.103391_bb0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12253-008-9026-z","article-title":"Recurrent pancreatic arteritis and vasculogenic relapsing pancreatitis in rheumatoid arthritis - a retrospective clinicopathologic and immunohistochemical study of 161 autopsy patients","volume":"14","author":"B\u00e9ly","year":"2008","journal-title":"Pathol Oncol Res POR"},{"issue":"4","key":"10.1016\/j.autrev.2023.103391_bb0055","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.20158","article-title":"Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001","volume":"50","author":"Ward","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2023.103391_bb0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14397595.2020.1795390","article-title":"Clinical characteristics and social productivity levels of patients with malignant rheumatoid arthritis based on a nationwide clinical database in Japan: annual survey from 2003 to 2013","volume":"31","author":"Abe","year":"2021","journal-title":"Mod Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103391_bb0065","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/art.24775","article-title":"Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study","volume":"60","author":"Bartels","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0070","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103391_bb0075","first-page":"1237","article-title":"Incidence and classification of cutaneous manifestations in rheumatoid arthritis","volume":"14","author":"Ziemer","year":"2016","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"issue":"10","key":"10.1016\/j.autrev.2023.103391_bb0080","first-page":"2287","article-title":"Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0085","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jbspin.2006.02.010","article-title":"CRI (Club Rhumatismes et inflammation). Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France","volume":"73","author":"Saint Marcoux","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0090","doi-asserted-by":"crossref","first-page":"R1386","DOI":"10.1186\/ar1837","article-title":"The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis","volume":"7","author":"Turesson","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.6061\/clinics\/2015(06)04","article-title":"The role of KIR2DL3\/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis","volume":"70","author":"Nishimura","year":"2015","journal-title":"Clin Sao Paulo Braz"},{"issue":"3","key":"10.1016\/j.autrev.2023.103391_bb0100","first-page":"366","article-title":"Association of HLA-DRB5*01 with protection against cutaneous manifestations of rheumatoid vasculitis in Brazilian patients","volume":"52","author":"Nishimura","year":"2012","journal-title":"Rev Bras Reumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0105","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2007.081679","article-title":"Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis","volume":"67","author":"Pu\u00e9chal","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103391_bb0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/03009748909099923","article-title":"Diminished clearance of soluble aggregates of human immunoglobulin G in patients with rheumatoid arthritis","volume":"18","author":"Lobatto","year":"1989","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103391_bb0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ard.50.5.284","article-title":"Uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis: relation to disease activity","volume":"50","author":"Heurkens","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103391_bb0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41584-021-00738-4","article-title":"The role of neutrophils in rheumatic disease-associated vascular inflammation","volume":"18","author":"Wang","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103391_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0090-1229(88)90084-0","article-title":"Immune complexes in sera from patients with rheumatoid vasculitis induce polymorphonuclear cell-mediated injury to endothelial cells","volume":"48","author":"Breedveld","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103391_bb0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jbspin.2016.05.013","article-title":"NETosis: at the crossroads of rheumatoid arthritis, lupus, and vasculitis","volume":"84","author":"Berthelot","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2023.103391_bb0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2019.01.003","article-title":"Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37","volume":"98","author":"Ribon","year":"2019","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.autrev.2023.103391_bb0140","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.3390\/ijms23073793","article-title":"The expanding role of extracellular traps in inflammation and autoimmunity: the new players in casting dark webs","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.autrev.2023.103391_bb0145","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1002\/art.22208","article-title":"Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis","volume":"54","author":"Matsunawa","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2023.103391_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.57.2.114","article-title":"The diagnostic value of perivascular infiltrates in muscle biopsy specimens for the assessment of rheumatoid vasculitis","volume":"57","author":"Voskuyl","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2023.103391_bb0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.62.5.407","article-title":"Diagnostic strategy for the assessment of rheumatoid vasculitis","volume":"62","author":"Voskuyl","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2023.103391_bb0160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1084\/jem.193.10.1159","article-title":"Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis","volume":"193","author":"Yen","year":"2001","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103391_bb0165","first-page":"7","article-title":"Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis","volume":"78","author":"Heurkens","year":"1989","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0170","first-page":"589","article-title":"Characterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis","volume":"9","author":"van der Zee","year":"1991","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103391_bb0175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00005792-198107000-00004","article-title":"Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases","volume":"60","author":"Scott","year":"1981","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103391_bb0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semarthrit.2006.04.006","article-title":"Systemic rheumatoid vasculitis: a review","volume":"36","author":"Genta","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2023.103391_bb0185","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1365-2133.2002.04933.x","article-title":"Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis","volume":"147","author":"Chen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2023.103391_bb0190","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0021-9681(63)90139-5","article-title":"The natural history of vascular lesions in rheumatoid arthritis","volume":"16","author":"Bywaters","year":"1963","journal-title":"J Chronic Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103391_bb0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000051716","article-title":"Bywater\u2019s lesions","volume":"203","author":"Boulinguez","year":"2001","journal-title":"Dermatol Basel Switz"},{"issue":"11","key":"10.1016\/j.autrev.2023.103391_bb0200","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.1780381114","article-title":"Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients","volume":"38","author":"Pu\u00e9chal","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0205","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00415-005-0833-9","article-title":"Primary and secondary vasculitic neuropathy","volume":"252","author":"Said","year":"2005","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103391_bb0210","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/rheumatology\/38.12.1245","article-title":"Peripheral ulcerative keratitis \u201ccorneal melt\u201d and rheumatoid arthritis: a case series","volume":"38","author":"Squirrell","year":"1999","journal-title":"Rheumatol Oxf Engl."},{"issue":"4","key":"10.1016\/j.autrev.2023.103391_bb0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","article-title":"Scleritis","volume":"50","author":"Okhravi","year":"2005","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103391_bb0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/art.1780390213","article-title":"The mortality of rheumatoid vasculitis compared with rheumatoid arthritis","volume":"39","author":"Voskuyl","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2023.103391_bb0225","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.59.8.598","article-title":"Increased cellularity and expression of adhesion molecules in muscle biopsy specimens from patients with rheumatoid arthritis with clinical suspicion of vasculitis, but negative routine histology","volume":"59","author":"Verschueren","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"10.1016\/j.autrev.2023.103391_bb0230","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/1097-0258(20001230)19:24<3433::AID-SIM647>3.0.CO;2-J","article-title":"Diagnostic strategies for the histological examination of muscle biopsy specimens for the assessment of vasculitis in rheumatoid arthritis","volume":"19","author":"Zwinderman","year":"2000","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.autrev.2023.103391_bb0235","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3899\/jrheum.181397","article-title":"Rituximab therapy for systemic rheumatoid VASCULITIS: indications, outcomes, and adverse events","volume":"47","author":"Coffey","year":"2020","journal-title":"J Rheumatol"},{"issue":"6 Suppl 18","key":"10.1016\/j.autrev.2023.103391_bb0240","first-page":"S91","article-title":"Clinical experience with combination disease-modifying antirheumatic drug therapy with cyclosporine","volume":"17","author":"Johns","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103391_bb0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/BOR.0000000000000126","article-title":"Rheumatoid vasculitis: an update","volume":"27","author":"Makol","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0250","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11926-010-0130-1","article-title":"Rheumatoid vasculitis: vanishing menace or target for new treatments?","volume":"12","author":"Bartels","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"1 Suppl 57","key":"10.1016\/j.autrev.2023.103391_bb0255","first-page":"81","article-title":"Rituximab in patients with rheumatoid arthritis and vasculitis-associated cutaneous ulcers","volume":"28","author":"Assmann","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103391_bb0260","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/ard.2007.083584","article-title":"Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients","volume":"67","author":"Josselin","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2023.103391_bb0265","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatol Oxf Engl."},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0270","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/03009742.2012.695803","article-title":"Extra-articular manifestations in a community-based sample of patients with rheumatoid arthritis: incidence and relationship to treatment with TNF inhibitors","volume":"41","author":"Nyh\u00e4ll-W\u00e5hlin","year":"2012","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103391_bb0275","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/annrheumdis-2018-214598","article-title":"Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database","volume":"78","author":"Arnaud","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103391_bb0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/acr.20689","article-title":"Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: results from the AutoImmunity and rituximab registry","volume":"64","author":"Pu\u00e9chal","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.autrev.2023.103391_bb0285","doi-asserted-by":"crossref","first-page":"585","DOI":"10.5694\/j.1326-5377.1990.tb126267.x","article-title":"Leg ulcers in rheumatoid arthritis","volume":"153","author":"Pun","year":"1990","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0290","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10067-011-1710-9","article-title":"Lower extremity ulcers in rheumatoid arthritis: features and response to immunosuppression","volume":"30","author":"Shanmugam","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103391_bb0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cup.12690","article-title":"Methotrexate-associated EBV-positive vasculitis in the skin: a report of two cases simulating rheumatoid vasculitis","volume":"43","author":"Fujimoto","year":"2016","journal-title":"J Cutan Pathol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:34Z","timestamp":1761600454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1568997223001258"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103391","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid vasculitis in 2023: Changes and challenges since the biologics era","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103391"}}